Never seen a more derisked biotech.
Already being used in overseas markets with solid prescription growth. Printing cash.
FDA ticked everything off except the product use label.
A team that knows how to launch products, heavily involved in sale of Anacor to Pfizer for $5.2 billion us dollars.
Extinguished royalty payments going forward.
Focus on telehealth prescriptions with major US partner signed.
Diversified future pipeline in acne, rosacea and antibiotic arms.
Insane opportunity awaits.
BOT - Anything but charting, page-6704
-
- There are more pages in this discussion • 2,398 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $615.4M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 34.0¢ | 32.8¢ | $1.949M | 5.840M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2985 | 33.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 420471 | 4 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |